Resvita Bio (Seed+)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Valuation
$20,000,000
Company Info
Founders
Amin Zargar
Market
Healthcare & Wellness
Coinvestors
Pioneer Fund
Company Description

Developer of skin probiotics technology designed to treat chronic skin diseases. Resvita Bio develops and manufactures engineered probiotics for use in treatment if skin related diseases including cancer.